Variation Biotechnologies (US), Inc. — Form D
Variation Biotechnologies (US), Inc. of CAMBRIDGE, MA, a company, filed a Form D exempt-offering notice with the SEC on 2011-07-15. The offering totals $3.5M, of which $3.5M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2011-07-15
- Form: D
- Accession: 0001525594-11-000002
- Industry: Biotechnology
- Exemptions: 06
- Total offering: $3.5M
- Amount sold: $3.5M
- Investors: 4
- Date of first sale: 2011-06-03
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-162994
Issuer
- Name: Variation Biotechnologies (US), Inc.
- CIK: 0001525594
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2006
- Address: 222 3RD STREET, CAMBRIDGE, MA, 02142
- Phone: (617) 830-3031
Officers, directors & promoters (16)
| Name | Role | Location |
|---|
| Jeffrey Leiden | Director | Rochester, NY |
| Steve Gillis | Director | New York, NY |
| Steven Gillis | Director | South San Francisco, CA |
| David E Anderson | Executive Officer | San Diego, CA |
| Scott Rocklage | Director | Menlo Park, CA |
| Jeff Baxter | Director | Cambridge, MA |
| Jeff Baxter | Executive Officer | Cambridge, MA |
| Kevin Forrest | Director | San Diego, CA |
| Stephen Gillis | Director | Cambridge, MA |
| EGIDIO NASCIMENTO | Executive Officer | CAMBRIDGE, MA |
| Michael Steinmetz | Director | Ann Arbor, MI |
| Steve Vignau | Director | Cambridge, MA |
| Marc J Kirchmeier | Executive Officer | Cambridge, MA |
| Steve E Vignau | Director | Cambridge, MA |
| Adam E Buckley | Executive Officer | Cambridge, MA |
| STEVEN VIGNAU | Director | CAMBRIDGE, MA |
Other filings by this issuer (9)
More